Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT06728657
What this trial is testing

Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma

Who this might be right for
Stomach AdenocarcinomaGastro-esophageal Junction Cancer
Fudan University 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07142200
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
RenJi Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT05053802
What this trial is testing

Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial

Who this might be right for
Multiple Primary Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT06342167
What this trial is testing

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell CarcinomaSintilimabRadiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 57
Large-scale testing (Phase 3)Active Not RecruitingNCT05671510
What this trial is testing

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
OncoC4, Inc. 630
Large-scale testing (Phase 3)Looking for participantsNCT06958432
What this trial is testing

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Who this might be right for
Rectal CancerNeoadjuvant TherapiesImmune Checkpoint Therapy+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 430
Early research (Phase 1)Study completedNCT05025085
What this trial is testing

A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Agenus Inc. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552558
What this trial is testing

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV-Negative Squamous Cell Carcinoma
Washington University School of Medicine 45
Testing effectiveness (Phase 2)UnknownNCT05207735
What this trial is testing

PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.

Who this might be right for
Cholangiocarcinoma
Henan Cancer Hospital 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06986057
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant Therapy
Shandong Tumor Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT07248956
What this trial is testing

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Who this might be right for
Hypopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 116
Testing effectiveness (Phase 2)Looking for participantsNCT06204094
What this trial is testing

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Jinhua Central Hospital 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05200559
What this trial is testing

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors

Who this might be right for
Epithelial Ovarian Cancer
Alexander B Olawaiye, MD 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06871527
What this trial is testing

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Who this might be right for
Gastric (Stomach) CancerGastric AdenocarcinomaFruquintinib+3 more
Sixth Affiliated Hospital, Sun Yat-sen University 44
Not applicableLooking for participantsNCT05486650
What this trial is testing

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Who this might be right for
Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 20
Testing effectiveness (Phase 2)Looking for participantsNCT06100497
What this trial is testing

Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Beijing Tongren Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT05980715
What this trial is testing

PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy

Who this might be right for
HNSCCRadiotherapyPD-1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 324
Early research (Phase 1)Looking for participantsNCT05187182
What this trial is testing

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerStomach Cancer+2 more
Washington University School of Medicine 42
Not applicableStudy completedNCT04253080
What this trial is testing

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Who this might be right for
Cutaneous Melanoma
Assistance Publique - Hôpitaux de Paris 127
Not applicableLooking for participantsNCT06915389
What this trial is testing

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

Who this might be right for
Gastric CancerImmunotherapyAdverse Event+2 more
Qinghai Red Cross Hospital 100
Next Page